Approval of Denosumab biosimilar and launch of teriparatide biosimilar in China and South Korea

Published date25 June 2020
Subject MatterChina,Prescription Drugs,Biosimilars,South Korea,Pharmaceutical Industry
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT